TrialThe Lancet. Global health2024

The effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial.

Ludoviko Zirimenya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.